{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T22:58:11Z","timestamp":1774479491929,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.thromres.2021.03.018","type":"journal-article","created":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T06:23:28Z","timestamp":1616307808000},"page":"90-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Splanchnic vein thrombosis: Clinical manifestations, risk factors, management, and outcomes"],"prefix":"10.1016","volume":"202","author":[{"given":"Eri","family":"Kawata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dou-Anne","family":"Siew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Gordon","family":"Payne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Louzada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Lazo-Langner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2021.03.018_bb0005","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1160\/TH16-10-0781","article-title":"Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari syndrome","volume":"117","author":"Ageno","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.03.018_bb0010","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11739-010-0413-6","article-title":"Splanchnic vein thrombosis: clinical presentation, risk factors and treatment","volume":"5","author":"de Stefano","year":"2010","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.thromres.2021.03.018_bb0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cgh.2009.09.019","article-title":"Survival and recurrence in patients with splanchnic vein thromboses","volume":"8","author":"Thatipelli","year":"2010","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.thromres.2021.03.018_bb0020","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamainternmed.2015.3184","article-title":"Long-term clinical outcomes of splanchnic vein thrombosis results of an international registry","volume":"175","author":"Ageno","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.thromres.2021.03.018_bb0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11239-015-1308-1","article-title":"Guidance for the management of venous thrombosis in unusual sites","volume":"41","author":"Ageno","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2021.03.018_bb0030","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic Therapy for VTE Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest."},{"key":"10.1016\/j.thromres.2021.03.018_bb0035","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/S2352-3026(16)30020-5","article-title":"Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry","volume":"3","author":"Riva","year":"2016","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.thromres.2021.03.018_bb0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2018.02.143","article-title":"Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis","volume":"164","author":"Tufano","year":"2018","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2021.03.018_bb0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"EASL clinical practice guidelines: vascular diseases of the liver","volume":"64","author":"Garcia-Pag\u00e1n","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2021.03.018_bb0050","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2021.03.018_bb0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2010.11.006","article-title":"Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee","volume":"43","author":"Senzolo","year":"2011","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.thromres.2021.03.018_bb0060","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/hep.22772","article-title":"Vascular disorders of the liver","volume":"49","author":"DeLeve","year":"2009","journal-title":"Hepatology."},{"key":"10.1016\/j.thromres.2021.03.018_bb0065","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Subcommittee on control of anticoagulation of the Scientific and Standardization Committee of the International Society of Thrombosis an","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.03.018_bb0070","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.03.018_bb0075","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/j.1538-7836.2010.03937.x","article-title":"Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy","volume":"8","author":"Gatt","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.03.018_bb0080","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.2020006827","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis Anticoagulant therapy for splanchnic vein thrombosis: A systematic review and meta-analysis","volume":"137","author":"Valeriani","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2021.03.018_bb0085","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s40265-014-0301-x","article-title":"New oral anticoagulants for the treatment of venous thromboembolism: understanding differences and similarities","volume":"74","author":"Dobesh","year":"2014","journal-title":"Drugs."},{"key":"10.1016\/j.thromres.2021.03.018_bb0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/hepr.12895","article-title":"Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis","volume":"48","author":"Nagaoki","year":"2018","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.thromres.2021.03.018_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/8432781","article-title":"Newer Oral anticoagulants in the treatment of acute portal vein thrombosis in patients with and without cirrhosis","volume":"2018","author":"Priyanka","year":"2018","journal-title":"Int. J. Hepatol."},{"key":"10.1016\/j.thromres.2021.03.018_bb0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mayocp.2017.10.007","article-title":"Rivaroxaban and apixaban for initial treatment of acute venous thromboembolism of atypical location","volume":"93","author":"Janczak","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.thromres.2021.03.018_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-018-0100-9","article-title":"Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018","volume":"8","author":"Finazzi","year":"2018","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.thromres.2021.03.018_bb0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.vph.2018.05.002","article-title":"Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis","volume":"113","author":"Hanafy","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.thromres.2021.03.018_bb0115","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.blre.2018.01.002","article-title":"Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: a narrative review","volume":"32","author":"Bertoletti","year":"2018","journal-title":"Blood Rev."},{"key":"10.1016\/j.thromres.2021.03.018_bb0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.thromres.2018.12.019","article-title":"Natural history and clinical outcomes in patients with portal vein thrombosis by etiology: a retrospective cohort study","volume":"174","author":"Acuna-Villaorduna","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2021.03.018_bb0125","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1007\/s10620-019-05572-z","article-title":"Anticoagulation in cirrhosis and portal vein thrombosis is safe and improves prognosis in advanced cirrhosis","volume":"64","author":"Noronha Ferreira","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.thromres.2021.03.018_bb0130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41395-018-0421-0","article-title":"Clinical impact and safety of anticoagulants for portal vein thrombosis in cirrhosis","volume":"114","author":"Pettinari","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.thromres.2021.03.018_bb0135","first-page":"1","article-title":"Splanchnic vein thromboses associated with myeloproliferative neoplasms: an international, retrospective study on 518 cases","author":"Sant\u2019Antonio","year":"2019","journal-title":"Am. J. Hematol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821001092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821001092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:45:32Z","timestamp":1758735932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384821001092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":27,"alternative-id":["S0049384821001092"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2021.03.018","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Splanchnic vein thrombosis: Clinical manifestations, risk factors, management, and outcomes","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2021.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}